The Minimal Important Difference in the 6-Minute Walk Test for Patients with Pulmonary Arterial Hypertension

Addition of Sildenafil to Long-Term Intravenous Epoprostenol Therapy in Patients with Pulmonary Arterial Hypertension

(2013) Gérald Simonneau   ANNALS OF INTERNAL MEDICINE

Tadalafil monotherapy and as add-on to background bosentan in patients with pulmonary arterial hypertension

(2011) Robyn J. Barst et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Progressive Right Ventricular Dysfunction in Patients With Pulmonary Arterial Hypertension Responding to Therapy

(2011) Mariëlle C. van de Veerdonk et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Six-Minute-Walk Test in Idiopathic Pulmonary Fibrosis

(2010) Roland M. du Bois et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Updating the Minimal Important Difference for Six-Minute Walk Distance in Patients With Chronic Obstructive Pulmonary Disease

(2010) Anne E. Holland et al.   ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION

Clinically Significant Change in Stroke Volume in Pulmonary Hypertension

(2010) Serge A. van Wolferen et al.   CHEST

The minimal important difference of exercise tests in severe COPD

(2010) M. A. Puhan et al.   EUROPEAN RESPIRATORY JOURNAL

Tadalafil Therapy for Pulmonary Arterial Hypertension

(2009) Nazzareno Galiè et al.   CIRCULATION

Tadalafil therapy and health-related quality of life in pulmonary arterial hypertension

(2009) Joanna Pepke-Zaba et al.   CURRENT MEDICAL RESEARCH AND OPINION

The minimal detectable change cannot reliably replace the minimal important difference

(2009) Dan Turner et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

End Points and Clinical Trial Design in Pulmonary Arterial Hypertension

(2009) Vallerie V. McLaughlin et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension

(2009) Vallerie V. McLaughlin et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Small changes in six-minute walk distance are important in diffuse parenchymal lung disease

(2009) Anne E. Holland et al.   RESPIRATORY MEDICINE

Sildenafil Improves Health-Related Quality of Life in Patients With Pulmonary Arterial Hypertension*

(2008) Joanna Pepke-Zaba et al.   CHEST

Estimating a Minimally Important Difference in Pulmonary Arterial Hypertension Following Treatment With Sildenafil

(2008) Claire Gilbert et al.   CHEST

Ambrisentan for the Treatment of Pulmonary Arterial Hypertension

(2008) Nazzareno Galiè et al.   CIRCULATION

Interpretation of treatment changes in 6-minute walk distance in patients with COPD

(2008) M. A. Puhan et al.   EUROPEAN RESPIRATORY JOURNAL

Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes

(2007) Dennis Revicki et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY